The University of Chicago Header Logo

Connection

Gaurav Upadhyay to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Gaurav Upadhyay has written about Treatment Outcome.
Gaurav Upadhyay
Connection Strength
1.578
Treatment Outcome
  1. Conduction System Pacing With Stylet Driven Leads: A Step-By-Step Guide to Implant. J Cardiovasc Electrophysiol. 2025 10; 36(10):2587-2596.
    View in: PubMed
    Score: 0.087
  2. The evolution of conduction system pacing and gaps in understanding. Prog Cardiovasc Dis. 2025 Jul-Aug; 91:113-120.
    View in: PubMed
    Score: 0.086
  3. Clinical outcomes of conduction system pacing compared to biventricular pacing in patients with mid-range ejection fraction. J Interv Card Electrophysiol. 2025 Jan; 68(1):111-116.
    View in: PubMed
    Score: 0.081
  4. Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring. J Am Coll Cardiol. 2023 03 14; 81(10):949-961.
    View in: PubMed
    Score: 0.074
  5. Physiologic Pacing Targeting the His Bundle and Left Bundle Branch: a Review of the Literature. Curr Cardiol Rep. 2022 08; 24(8):959-978.
    View in: PubMed
    Score: 0.070
  6. Population-Level Impact of the Guidelines Update on Patient Selection and Outcomes After Cardiac Resynchronization Therapy. JACC Clin Electrophysiol. 2022 05; 8(5):651-661.
    View in: PubMed
    Score: 0.069
  7. Bradyarrhythmias and Physiologic Pacing in the ICU. J Intensive Care Med. 2022 May; 37(5):595-610.
    View in: PubMed
    Score: 0.065
  8. Keeping pace with the competition: His bundle versus biventricular pacing in heart failure. Curr Opin Cardiol. 2020 05; 35(3):295-307.
    View in: PubMed
    Score: 0.061
  9. Catheter Ablation for Atrial Fibrillation in 2019. JAMA. 2019 08 20; 322(7):686-687.
    View in: PubMed
    Score: 0.058
  10. On-treatment comparison between corrective His bundle pacing and biventricular pacing for cardiac resynchronization: A secondary analysis of the His-SYNC Pilot Trial. Heart Rhythm. 2019 12; 16(12):1797-1807.
    View in: PubMed
    Score: 0.057
  11. Pushing and recognizing the limits of nonresponse to cardiac resynchronization therapy: A valuable "negative" trial. Heart Rhythm. 2018 06; 15(6):877-878.
    View in: PubMed
    Score: 0.052
  12. Does Cardiac Resynchronization Therapy Benefit Patients with Non-Left Bundle Branch Block Prolonged QRS Patterns? Curr Cardiol Rep. 2017 10 24; 19(12):125.
    View in: PubMed
    Score: 0.051
  13. Selective versus non-selective his bundle pacing for cardiac resynchronization therapy. J Electrocardiol. 2017 Mar - Apr; 50(2):191-194.
    View in: PubMed
    Score: 0.047
  14. Cause of death and CRT device selection: striving for certitude? Eur Heart J. 2015 Nov 01; 36(41):2777-9.
    View in: PubMed
    Score: 0.044
  15. Assessing mitral regurgitation in the prediction of clinical outcome after cardiac resynchronization therapy. Heart Rhythm. 2015 Jun; 12(6):1201-8.
    View in: PubMed
    Score: 0.042
  16. Optimal pace timing for left bundle branch area pacing with or without an additional LV lead: results from the CSPOT study. Europace. 2026 May 06; 28(5).
    View in: PubMed
    Score: 0.023
  17. Cardioneural Ablation for Functional Bradycardia and Vasovagal Syncope: Outcomes From the U.S. Multicenter CNA Registry. JACC Clin Electrophysiol. 2025 08; 11(8):1683-1695.
    View in: PubMed
    Score: 0.021
  18. Left bundle branch area pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with left ventricular ejection fraction =50%: Results from the International Collaborative LBBAP Study (I-CLAS). Heart Rhythm. 2025 08; 22(8):2028-2037.
    View in: PubMed
    Score: 0.021
  19. Echocardiographic response from left bundle branch area pacing optimized cardiac resynchronization therapy (LOT-CRT) vs traditional CRT. Heart Rhythm. 2025 10; 22(10):2616-2624.
    View in: PubMed
    Score: 0.021
  20. Performance of an active fixation stylet-driven lead in left bundle branch area pacing: Results from INSIGHT-LBBA. Heart Rhythm. 2025 08; 22(8):2047-2054.
    View in: PubMed
    Score: 0.021
  21. Inappropriate Therapy and Shock Rates Between the Subcutaneous and Transvenous Implantable Cardiac Defibrillator: A Secondary Analysis of the PRAETORIAN Trial. Circ Arrhythm Electrophysiol. 2024 Dec; 17(12):e012836.
    View in: PubMed
    Score: 0.021
  22. Quality of Life in Subcutaneous or Transvenous Implantable Cardioverter-Defibrillator Patients: A Secondary Analysis of the PRAETORIAN Trial. Circ Cardiovasc Qual Outcomes. 2024 11; 17(11):e010822.
    View in: PubMed
    Score: 0.021
  23. Multicenter Hemodynamic Assessment of the LOT-CRT Strategy: When Does Combining Left Bundle Branch Pacing and Coronary Venous Pacing Enhance Resynchronization?: Primary Results of the CSPOT Study. Circ Arrhythm Electrophysiol. 2024 Nov; 17(11):e013059.
    View in: PubMed
    Score: 0.021
  24. Conduction system pacing compared with biventricular pacing for cardiac resynchronization therapy in patients with heart failure and mildly reduced left ventricular ejection fraction: Results from International Collaborative LBBAP Study (I-CLAS) Group. Heart Rhythm. 2025 06; 22(6):1512-1522.
    View in: PubMed
    Score: 0.021
  25. Association between COVID-19 vaccination and atrial arrhythmias in individuals with cardiac implantable electronic devices. J Cardiovasc Electrophysiol. 2024 09; 35(9):1828-1836.
    View in: PubMed
    Score: 0.020
  26. Predictors of Shock-Reduction Programming and Its Impact on Implantable Cardioverter-Defibrillator Therapies and Mortality: The CERTITUDE Registry. J Am Heart Assoc. 2024 08 06; 13(15):e034500.
    View in: PubMed
    Score: 0.020
  27. Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry. Europace. 2024 07 02; 26(7).
    View in: PubMed
    Score: 0.020
  28. Septal venous channel perforation during left bundle branch area pacing: a prospective study. Europace. 2024 Jun 03; 26(6).
    View in: PubMed
    Score: 0.020
  29. Cardioneuroablation for the management of patients with recurrent vasovagal syncope and symptomatic bradyarrhythmias: the CNA-FWRD Registry. J Interv Card Electrophysiol. 2025 Mar; 68(2):183-191.
    View in: PubMed
    Score: 0.020
  30. Side-to-side isoperistaltic strictureplasty in the treatment of extensive Crohn's disease. J Surg Res. 2004 Mar; 117(1):71-8.
    View in: PubMed
    Score: 0.020
  31. Left Bundle Branch Block: Characterization, Definitions, and Recent Insights into Conduction System Physiology. Cardiol Clin. 2023 Aug; 41(3):379-391.
    View in: PubMed
    Score: 0.019
  32. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System. J Am Coll Cardiol. 2023 08 01; 82(5):383-397.
    View in: PubMed
    Score: 0.019
  33. 2023 HRS/APHRS/LAHRS guideline on cardiac physiologic pacing for the avoidance and mitigation of heart failure. Heart Rhythm. 2023 09; 20(9):e17-e91.
    View in: PubMed
    Score: 0.019
  34. Device-related complications in subcutaneous versus transvenous ICD: a secondary analysis of the PRAETORIAN trial. Eur Heart J. 2022 12 14; 43(47):4872-4883.
    View in: PubMed
    Score: 0.018
  35. Rescue left bundle branch area pacing in coronary venous lead failure or nonresponse to biventricular pacing: Results from International LBBAP Collaborative Study Group. Heart Rhythm. 2022 08; 19(8):1272-1280.
    View in: PubMed
    Score: 0.017
  36. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial. Circulation. 2022 02; 145(5):321-329.
    View in: PubMed
    Score: 0.017
  37. Left ventricle and mitral valve reverse remodeling in response to cardiac resynchronization therapy in nonischemic cardiomyopathy. Echocardiography. 2020 10; 37(10):1557-1565.
    View in: PubMed
    Score: 0.016
  38. Characterization of Lead Adherence Using Intravascular Ultrasound to Assess Difficulty of Transvenous Lead Extraction. Circ Arrhythm Electrophysiol. 2020 08; 13(8):e007726.
    View in: PubMed
    Score: 0.015
  39. The effects of cardiac resynchronization therapy on left ventricular and mitral valve geometry and secondary mitral regurgitation in patients with left bundle branch block. Echocardiography. 2019 08; 36(8):1450-1458.
    View in: PubMed
    Score: 0.014
  40. Effects of cardiac resynchronization therapy after inferior myocardial infarction on secondary mitral regurgitation and mitral valve geometry. Pacing Clin Electrophysiol. 2018 02; 41(2):114-121.
    View in: PubMed
    Score: 0.013
  41. Impact of cardiac resynchronization therapy on mitral valve apparatus geometry and clinical outcomes in patients with secondary mitral regurgitation. Echocardiography. 2017 Nov; 34(11):1561-1567.
    View in: PubMed
    Score: 0.013
  42. Characterization of Ventricular Tachycardia After Left Ventricular Assist Device Implantation as Destination Therapy: A Single-Center Ablation Experience. JACC Clin Electrophysiol. 2017 12 11; 3(12):1412-1424.
    View in: PubMed
    Score: 0.013
  43. Permanent His-bundle pacing for cardiac resynchronization therapy: Initial feasibility study in lieu of left ventricular lead. Heart Rhythm. 2017 09; 14(9):1353-1361.
    View in: PubMed
    Score: 0.012
  44. Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol. 2015 Oct; 38(10):1192-200.
    View in: PubMed
    Score: 0.011
  45. Does prior valve surgery change outcome in patients treated with cardiac resynchronization therapy? J Cardiovasc Electrophysiol. 2014 Nov; 25(11):1206-13.
    View in: PubMed
    Score: 0.010
  46. Pre-capillary pulmonary hypertension and right ventricular dilation predict clinical outcome in cardiac resynchronization therapy. JACC Heart Fail. 2014 Jun; 2(3):230-7.
    View in: PubMed
    Score: 0.010
  47. Device-measured physical activity versus six-minute walk test as a predictor of reverse remodeling and outcome after cardiac resynchronization therapy for heart failure. Am J Cardiol. 2014 May 01; 113(9):1523-8.
    View in: PubMed
    Score: 0.010
  48. Impact of myocardial viability and left ventricular lead location on clinical outcome in cardiac resynchronization therapy recipients with ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014 May; 25(5):507-513.
    View in: PubMed
    Score: 0.010
  49. QRS morphology, left ventricular lead location, and clinical outcome in patients receiving cardiac resynchronization therapy. Eur Heart J. 2013 Aug; 34(29):2252-62.
    View in: PubMed
    Score: 0.009
  50. The anatomic and electrical location of the left ventricular lead predicts ventricular arrhythmia in cardiac resynchronization therapy. Heart Rhythm. 2013 May; 10(5):668-75.
    View in: PubMed
    Score: 0.009
  51. Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study. J Interv Card Electrophysiol. 2013 Apr; 36(3):223-31.
    View in: PubMed
    Score: 0.009
  52. Electrical delay in apically positioned left ventricular leads and clinical outcome after cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2013 Feb; 24(2):182-7.
    View in: PubMed
    Score: 0.009
  53. Usefulness of hemoglobin A(1c) to predict outcome after cardiac resynchronization therapy in patients with diabetes mellitus and heart failure. Am J Cardiol. 2012 Sep 01; 110(5):683-8.
    View in: PubMed
    Score: 0.009
  54. Multidisciplinary care of patients receiving cardiac resynchronization therapy is associated with improved clinical outcomes. Eur Heart J. 2012 Sep; 33(17):2181-8.
    View in: PubMed
    Score: 0.009
  55. Pulmonary vein isolation with complex fractionated atrial electrogram ablation for paroxysmal and nonparoxysmal atrial fibrillation: A meta-analysis. Heart Rhythm. 2011 Jul; 8(7):994-1000.
    View in: PubMed
    Score: 0.008
  56. An international, multicenter, prospective, observational study of the side-to-side isoperistaltic strictureplasty in Crohn's disease. Dis Colon Rectum. 2007 Mar; 50(3):277-84.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.